The effect of statins on blood gene expression in COPD

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Obeidat, Ma'en ^a   Fishbane, Nick ^a   Nie, Yunlong ^a   Chen, Virginia ^b   Hollander, Zsuzsanna ^b   Tebbutt, Scott J ^a,b,c   Bossé, Yohan ^d   Ng, Raymond T ^b   Miller, Bruce E ^e   McManus, Bruce ^a,b   Rennard, Stephen ^f   Paré, Peter D ^a,c   Sin, Don D ^a,c  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^b NCE CECR Prevention of Organ Failure (PROOF) Centre of Excellence   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CHEMOKINE RECEPTOR CXCR2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; TRANSCRIPTOME;

ABCG1 GENE; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL METABOLISM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CXCR2 GENE; DHCR24 GENE; DRUG EFFECT; DRUG USE; FAM108A1 GENE; FEMALE; FRYL GENE; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUNTINGTON CHOREA; IFI35 GENE; LDLR GENE; MAJOR CLINICAL STUDY; MALE; MYLIP GENE; PARKINSON DISEASE; SC4MOL GENE; BLOOD; DEMOGRAPHY; GENE ONTOLOGY; GENETICS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; DEMOGRAPHY; FEMALE; GENE ONTOLOGY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSCRIPTOME;

EID: 84949035652     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140022     Document Type: Article

References (68)

1. GOLD. Global Initiative for Chronic Obstructive Lung disease 2011.
2. Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. The Lancet Respiratory Medicine. 2013; 1(1):73-83. doi: 10.1016/S2213-2600(12)70060-7 PMID: 24321806
3. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. The Lancet. 1997; 349(9064):1498-504.
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20?536 high-risk individuals: A randomised placebocontrolled trial. The Lancet. 2002; 360(9326):7-22.
5. Arnaud C, Burger F, Steffens S, Veillard NR, Nguyen TH, Trono D, et al. Statins Reduce Interleukin-6-Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005; 25(6):1231-6. PMID: 15790934
6. Young RP, Hopkins R, Eaton TE. Pharmacological actions of statins: Potential utility in COPD. European Respiratory Review. 2009; 18(114):222-32. doi: 10.1183/09059180.00005309 PMID: 20956147
7. Blamoun AI, Batty GN, DeBari VA, Rashid AO, Sheikh M, Khan MA. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: Evidence from a retrospective cohort study. International Journal of Clinical Practice. 2008; 62(9):1373-8. doi: 10.1111/j.1742-1241. 2008.01731.x PMID: 18422598
8. Alexeeff SE, Litonjua AA, Sparrow D, Vokonas PS, Schwartz J. Statin Use Reduces Decline in Lung Function. American Journal of Respiratory and Critical Care Medicine. 2007; 176(8):742-7. PMID: 17673694
9. Frost FJ, Petersen H, Tollestrup K, Skipper B. INfluenza and copd mortality protection as pleiotropic, dose-dependent effects of statins∗. Chest. 2007; 131(4):1006-12. PMID: 17426203
10. Horita N, Miyazawa N, Kojima R, Inoue M, Ishigatsubo Y, Ueda A, et al. Statins reduce all-cause mortality in chronic obstructive pulmonary disease: A systematic review and meta-analysis of observational studies. Respiratory Research. 2014; 15(1):80.
11. Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins in copd: A systematic review. Chest. 2009; 136(3):734-43. doi: 10.1378/chest.09-0194 PMID: 19376844
12. Dobler C, Wong K, Marks G. Associations between statins and COPD: A systematic review. BMC Pulmonary Medicine. 2009; 9(1):32.
13. Cirillo DJ, Agrawal Y, Cassano PA. Lipids and Pulmonary Function in the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology. 2002; 155(9):842-8. PMID: 11978588
14. Shen Y, Yang T, Guo S, Li X, Chen L, Wang T, et al. Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD. Mediators of inflammation. 2013; 2013:972347. Epub 2013/10/01. doi: 10.1155/2013/972347 PMID: 24078777
15. Burkart KM, Manichaikul A, Wilk JB, Ahmed FS, Burke GL, Enright P, et al. APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema. European Respiratory Journal. 2014; 43(4):1003-17. doi: 10.1183/09031936.00147612 PMID: 23900982
16. Tisi GM, Conrique A, Barrett-Connor E, Grundy SM. Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type). Metabolism. 1981; 30(4):340-6. PMID: 7207205
17. Reed RM, Iacono A, DeFilippis A, Eberlein M, Girgis RE, Jones S. Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol. The Journal of heart and lung transplantation: The official publication of the International Society for Heart Transplantation. 2011; 30(6):674-8. Epub 2011/02/11.
18. Nistor A, Simionescu M. Uptake of low density lipoproteins by the hamster lung. Interactions with capillary endothelium. The American review of respiratory disease. 1986; 134(6):1266-72. Epub 1986/12/01. PMID: 3024539
19. Hass MA, Longmore WJ. Regulation of lung surfactant cholesterol metabolism by serum lipopoteins. Lipids. 1980; 15(6):401-6. Epub 1980/06/01. PMID: 7401938
20. Gowdy KM, Fessler MB. Emerging roles for cholesterol and lipoproteins in lung disease. Pulmonary pharmacology & therapeutics. 2013; 26(4):430-7. Epub 2012/06/19. doi: 10.1016/j.pupt.2012.06.002 PMID: 22706330
21. Azzam KM, Fessler MB. Crosstalk between reverse cholesterol transport and innate immunity. Trends in Endocrinology & Metabolism. 2012; 23(4):169-78. doi: 10.1016/j.tem.2012.02.001 PMID: 22406271
22. Davis BB, Zeki AA, Bratt JM, Wang L, Filosto S, Walby WF, et al. Simvastatin inhibits smoke-induced airway epithelial injury: Implications for COPD therapy. The European respiratory journal. 2013; 42 (2):350-61. Epub 2012/11/28. doi: 10.1183/09031936.00042512 PMID: 23180589
23. Wright JL, Zhou S, Preobrazhenska O, Marshall C, Sin DD, Laher I, et al. Statin reverses smokeinduced pulmonary hypertension and prevents emphysema but not airway remodeling. Am J Respir Crit Care Med. 2011; 183(1):50-8. Epub 2010/08/17. doi: 10.1164/rccm.201003-0399OC PMID: 20709821
24. Criner GJ, Connett JE, Aaron SD, Albert RK, Bailey WC, Casaburi R, et al. Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD. New England Journal of Medicine. 2014; 370 (23):2201-10. doi: 10.1056/NEJMoa1403086 PMID: 24836125
25. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). The European respiratory journal. 2008; 31(4):869-73. Epub 2008/01/25. doi: 10.1183/09031936.00111707 PMID: 18216052
26. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010; 26(19):2363-7. doi: 10.1093/bioinformatics/btq431 PMID: 20688976
27. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4 (2):249-64. Epub 2003/08/20. PMID: 12925520
28. Hochreiter S, Clevert D-A, Obermayer K. A new summarization method for affymetrix probe level data. Bioinformatics (Oxford, England). 2006; 22(8):943-9.
29. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology. 2004; 3:Article3. Epub 2006/05/02.
30. Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate behavioral research. 2011; 46(3):399-424. PMID: 21818162
31. Leek JT, Storey JD. Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis. PLoS Genet. 2007; 3(9):e161.
32. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (Oxford, England). 2012; 28(6):882-3. Epub 2012/01/20.
33. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): Update 2013. Nucleic Acids Research. 2013; 41(W1):W77-W83.
34. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004; 32(Database issue):D277-80. Epub 2003/12/19. PMID: 14681412
35. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. Epub 2000/05/10. PMID: 10802651
36. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007; 23(2):257-8. PMID: 17098774
37. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995; 57(1):289-300.
38. Auerbach RK, Chen B, Butte AJ. Relating Genes to Function: Identifying Enriched Transcription Factors using the ENCODE ChIP-Seq Significance Tool. Bioinformatics. 2013.
39. Engreitz JM, Chen R, Morgan AA, Dudley JT, Mallelwar R, Butte AJ. ProfileChaser: Searching microarray repositories based on genome-wide patterns of differential expression. Bioinformatics (Oxford, England). 2011; 27(23):3317-8. Epub 2011/10/05.
40. Stancu C, Sima A. Statins: Mechanism of action and effects. Journal of cellular and molecular medicine. 2001; 5(4):378-87. Epub 2002/06/18. PMID: 12067471
41. Miserez AR, Muller PY, Barella L, Barella S, Staehelin HB, Leitersdorf E, et al. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia. Atherosclerosis. 2002; 164(1):15-26. Epub 2002/07/18. PMID: 12119189
42. Wong J, Quinn CM, Brown AJ. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem J. 2006; 400(3):485-91. PMID: 16901265
43. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear Receptors and Lipid Physiology: Opening the X-Files. Science. 2001; 294(5548):1866-70. PMID: 11729302
44. Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses. Arteriosclerosis, Thrombosis, and Vascular Biology. 2010; 30(2):139-43. doi: 10.1161/ATVBAHA.108.179283 PMID: 19797709
45. Genvigir FD, Rodrigues AC, Cerda A, Hirata MH, Curi R, Hirata RD. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells. Drug metabolism and drug interactions. 2011; 26(1):33-6. Epub 2011/03/23. doi: 10.1515/DMDI.2011.101 PMID: 21417795
46. Ramos MC, Sierra S, Ramirez C, Velasco J, Burgos JS. Simvastatin Modulates the Alzheimer's Disease-Related Gene seladin-1. Journal of Alzheimer's Disease. 2012; 28(2):297-301. doi: 10.3233/JAD-2011-111118 PMID: 21987590
47. McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, et al. Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol. 2009; 29(6):877-82. Epub 2009/03/28. doi: 10.1161/ATVBAHA.109.184663 PMID: 19325144
48. Sorrentino V, Fouchier SW, Motazacker MM, Nelson JK, Defesche JC, Dallinga-Thie GM, et al. Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein. European heart journal. 2013; 34(17):1292-7. Epub 2013/01/18. doi: 10.1093/eurheartj/ehs472 PMID: 23324548
49. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(31):11023-8. PMID: 16043692
50. Kumar A, Sharma N, Mishra J, Kalonia H. Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington's disease like symptoms and related cognitive dysfunction in rats. European journal of pharmacology. 2013; 709(1-3):1-12. Epub 2013/04/09. doi: 10.1016/j.ejphar. 2013.03.042 PMID: 23562615
51. Burke LP, Lewis LD, Perez RP. Ubiquinone does not rescue acute myeloid leukemia cells from growth inhibition by statins. Leukemia. 2003; 17(1):267-8. Epub 2003/01/17. PMID: 12529692
52. Holstein SA, Hohl RJ. Interaction of cytosine arabinoside and lovastatin in human leukemia cells. Leukemia research. 2001; 25(8):651-60. Epub 2001/06/09. PMID: 11397469
53. Crosbie J, Magnussen M, Dornbier R, Iannone A, Steele T. Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line. Biomarker Research. 2013; 1(1):33. doi: 10.1186/2050-7771-1-33 PMID: 24359683
54. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proceedings of the National Academy of Sciences. 2007; 104(3):955-60.
55. Dolga AM, Culmsee C, de Lau L, Winter Y, Oertel WH, Luiten PG, et al. Statins-increasing or reducing the risk of Parkinson's disease? Experimental neurology. 2011; 228(1):1-4. Epub 2010/11/30. doi: 10. 1016/j.expneurol.2010.11.013 PMID: 21111736
56. Roy A, Pahan K. Prospects of statins in Parkinson disease. The Neuroscientist: A review journal bringing neurobiology, neurology and psychiatry. 2011; 17(3):244-55. Epub 2011/01/22.
57. Massaro D, Massaro GD. Developmental Alveologenesis: New Roles for ApoE and LDL Receptor. Pediatr Res. 2011; 70(5):458-61. doi: 10.1038/pr.2011.683 PMID: 21796016
58. Goldklang M, Golovatch P, Zelonina T, Trischler J, Rabinowitz D, Lemaitre V, et al. Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice. American journal of physiology Lung cellular and molecular physiology. 2012; 302(11):L1200-8. Epub 2012/03/27. doi: 10.1152/ajplung.00454.2010 PMID: 22447954
59. Baldan A, Gomes AV, Ping P, Edwards PA. Loss of ABCG1 results in chronic pulmonary inflammation. Journal of immunology (Baltimore, Md: 1950). 2008; 180(5):3560-8. Epub 2008/02/23.
60. Wojcik AJ, Skaflen MD, Srinivasan S, Hedrick CC. A critical role for ABCG1 in macrophage inflammation and lung homeostasis. Journal of immunology (Baltimore, Md: 1950). 2008; 180(6):4273-82. Epub 2008/03/07.
61. Bates SR, Tao JQ, Collins HL, Francone OL, Rothblat GH. Pulmonary abnormalities due to ABCA1 deficiency in mice. American journal of physiology Lung cellular and molecular physiology. 2005; 289 (6):L980-9. Epub 2005/08/02. PMID: 16055479
62. Draper DW, Madenspacher JH, Dixon D, King DH, Remaley AT, Fessler MB. ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung. Am J Respir Crit Care Med. 2010; 182 (3):404-12. Epub 2010/04/17. doi: 10.1164/rccm.200910-1580OC PMID: 20395559
63. Zarbock A, Stadtmann A. CXCR2: From Bench to Bedside. Frontiers in Immunology. 2012; 3.
64. Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010; 120(7):2423-31. Epub 2010/06/03. doi: 10.1172/JCI41649 PMID: 20516641
65. Mei J, Liu Y, Dai N, Hoffmann C, Hudock KM, Zhang P, et al. Cxcr2 and Cxcl5 regulate the IL-17/GCSF axis and neutrophil homeostasis in mice. J Clin Invest. 2012; 122(3):974-86. Epub 2012/02/14. doi: 10.1172/JCI60588 PMID: 22326959
66. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, et al. Biopsy Neutrophilia, Neutrophil Chemokine and Receptor Gene Expression in Severe Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 2003; 168(8):968-75. PMID: 12857718
67. Leszczynska A, Gora M, Plochocka D, Hoser G, Szkopinska A, Koblowska M, et al. Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: A pilot study. Acta biochimica Polonica. 2011; 58(4):635-9. Epub 2011/12/02. PMID: 22132374
68. Andreux PA, Mouchiroud L, Wang X, Jovaisaite V, Mottis A, Bichet S, et al. A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans. Sci Rep. 2014; 4.